OXFORD TARGET THERAPEUTICS LIMITED
Company number 13886983 · Monitor this company
Executive summary
Oxford Target Therapeutics is showing healthy growth in intangible assets and equity, with a strong upward trend in cash reserves signaling improved liquidity. Despite ongoing negative working capital, the company is managing the typical cash flow challenges of a biotech startup investing heavily in R&D. Continued focus on working capital management and diversified funding will be essential to sustain growth and improve financial resilience.
Shareholders' funds
£196,094
Balance sheet as at 2025-07-31
Overview
- Company type
- Private Limited Company
- Incorporated
- 2022-02-02
- Employees
- 0 (2025 accounts · was 2 in 2024)
- Registered office
- Bioinnovation Hub, Tonge Building Oxford Brookes University, Gipsy Lane, Headington Campus, Oxford, Oxfordshire, United Kingdom, OX3 0BP
- Postcode
- OX3 0BP
- Accounts category
- Total Exemption Full
Accounts
- Last made up to
- 2025-07-31
- Next due by
- 2027-04-30
- Financial year end
- 31 July
Confirmation statement
- Last statement dated
- 2026-05-06
- Next due by
- 2027-05-20
Nature of business (SIC)
- 72110 Research and experimental development on biotechnology
Officers 2 current · 1 resigned
Contact details
- Website
- oxfordtargettherapeutics.com
OTT pioneers breakthrough oncology therapies, unlocking novel drug targets to combat cancer. Partner with us to revolutionize patient outcomes globally.
Competitors Oxford
This company ranks 61 among research and experimental development on biotechnology in Oxford.